Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine

A preliminary study

J. M. Stapleton, M. J. Eckardt, P. Martin, B. Adinoff, L. Roehrich, G. Bone, D. Rubinow, M. Linnoila

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The chronic effects of fluvoxamine (200 mg per day for 4 weeks) were studied in ten alcoholic organic brain syndrome patients in a double-blind cross-over design. Complete neuropsychological evaluation was performed as well as measurement of neurochemical changes in CSF. Fluvoxamine produced a small but significant improvement in memory performance. An analysis of fluvoxamine minus placebo difference scores showed a significant correlation between memory functioning and CSF 5HIAA levels. Alcohol amnestic syndrome patients who had the highest blood levels of fluvoxamine demonstrated the largest changes in CSF 5HIAA and improvement in memory performance under fluvoxamine. These findings implicate a role of serotonergic mechanisms in alcoholic organic brain syndrome and suggest that with individual titration of the drug dose, fluvoxamine might be a clinically useful agent in the treatment of this syndrome.

Original languageEnglish (US)
Pages (from-to)47-51
Number of pages5
JournalAdvances in Alcohol and Substance Abuse
Volume7
Issue number3-4
StatePublished - 1988

Fingerprint

Fluvoxamine
Serotonin Uptake Inhibitors
Brain
Alcohol Amnestic Disorder
Therapeutics
Cross-Over Studies
Placebos
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Stapleton, J. M., Eckardt, M. J., Martin, P., Adinoff, B., Roehrich, L., Bone, G., ... Linnoila, M. (1988). Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine: A preliminary study. Advances in Alcohol and Substance Abuse, 7(3-4), 47-51.

Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine : A preliminary study. / Stapleton, J. M.; Eckardt, M. J.; Martin, P.; Adinoff, B.; Roehrich, L.; Bone, G.; Rubinow, D.; Linnoila, M.

In: Advances in Alcohol and Substance Abuse, Vol. 7, No. 3-4, 1988, p. 47-51.

Research output: Contribution to journalArticle

Stapleton, JM, Eckardt, MJ, Martin, P, Adinoff, B, Roehrich, L, Bone, G, Rubinow, D & Linnoila, M 1988, 'Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine: A preliminary study', Advances in Alcohol and Substance Abuse, vol. 7, no. 3-4, pp. 47-51.
Stapleton, J. M. ; Eckardt, M. J. ; Martin, P. ; Adinoff, B. ; Roehrich, L. ; Bone, G. ; Rubinow, D. ; Linnoila, M. / Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine : A preliminary study. In: Advances in Alcohol and Substance Abuse. 1988 ; Vol. 7, No. 3-4. pp. 47-51.
@article{896e052c3c0c4447a93b30fc7f9e8ce6,
title = "Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine: A preliminary study",
abstract = "The chronic effects of fluvoxamine (200 mg per day for 4 weeks) were studied in ten alcoholic organic brain syndrome patients in a double-blind cross-over design. Complete neuropsychological evaluation was performed as well as measurement of neurochemical changes in CSF. Fluvoxamine produced a small but significant improvement in memory performance. An analysis of fluvoxamine minus placebo difference scores showed a significant correlation between memory functioning and CSF 5HIAA levels. Alcohol amnestic syndrome patients who had the highest blood levels of fluvoxamine demonstrated the largest changes in CSF 5HIAA and improvement in memory performance under fluvoxamine. These findings implicate a role of serotonergic mechanisms in alcoholic organic brain syndrome and suggest that with individual titration of the drug dose, fluvoxamine might be a clinically useful agent in the treatment of this syndrome.",
author = "Stapleton, {J. M.} and Eckardt, {M. J.} and P. Martin and B. Adinoff and L. Roehrich and G. Bone and D. Rubinow and M. Linnoila",
year = "1988",
language = "English (US)",
volume = "7",
pages = "47--51",
journal = "Journal of Addictive Diseases",
issn = "1055-0887",
publisher = "Routledge",
number = "3-4",

}

TY - JOUR

T1 - Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine

T2 - A preliminary study

AU - Stapleton, J. M.

AU - Eckardt, M. J.

AU - Martin, P.

AU - Adinoff, B.

AU - Roehrich, L.

AU - Bone, G.

AU - Rubinow, D.

AU - Linnoila, M.

PY - 1988

Y1 - 1988

N2 - The chronic effects of fluvoxamine (200 mg per day for 4 weeks) were studied in ten alcoholic organic brain syndrome patients in a double-blind cross-over design. Complete neuropsychological evaluation was performed as well as measurement of neurochemical changes in CSF. Fluvoxamine produced a small but significant improvement in memory performance. An analysis of fluvoxamine minus placebo difference scores showed a significant correlation between memory functioning and CSF 5HIAA levels. Alcohol amnestic syndrome patients who had the highest blood levels of fluvoxamine demonstrated the largest changes in CSF 5HIAA and improvement in memory performance under fluvoxamine. These findings implicate a role of serotonergic mechanisms in alcoholic organic brain syndrome and suggest that with individual titration of the drug dose, fluvoxamine might be a clinically useful agent in the treatment of this syndrome.

AB - The chronic effects of fluvoxamine (200 mg per day for 4 weeks) were studied in ten alcoholic organic brain syndrome patients in a double-blind cross-over design. Complete neuropsychological evaluation was performed as well as measurement of neurochemical changes in CSF. Fluvoxamine produced a small but significant improvement in memory performance. An analysis of fluvoxamine minus placebo difference scores showed a significant correlation between memory functioning and CSF 5HIAA levels. Alcohol amnestic syndrome patients who had the highest blood levels of fluvoxamine demonstrated the largest changes in CSF 5HIAA and improvement in memory performance under fluvoxamine. These findings implicate a role of serotonergic mechanisms in alcoholic organic brain syndrome and suggest that with individual titration of the drug dose, fluvoxamine might be a clinically useful agent in the treatment of this syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0024262122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024262122&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 47

EP - 51

JO - Journal of Addictive Diseases

JF - Journal of Addictive Diseases

SN - 1055-0887

IS - 3-4

ER -